Using a patient’s personal genetic makeup, a team of medical researchers led by a Connecticut Children’s gastroenterologist has discovered a new way to predict if a child newly diagnosed with Crohn’s disease will require major surgery within 3 to 5 years.
A $500,000 gift from the Reid R. Sacco Adolescent and Young Adult (AYA) Cancer Alliance will help Connecticut Children’s Medical Center expand the availability of clinical trials to adolescents and young adults with cancer, a patient population that has not seen as many therapeutic advances in cancer treatment over the past 30 years as compared with younger and older patient populations. The new gift brings the Alliance’s total giving to Connecticut Children’s to $1 million in memory of Gene and Lorraine Saccos’ son, Reid, who died in 2005 at the age of 20, following a two-year battle with sarcoma.
A Connecticut physician is seeking the public’s help in finding new effective treatments for childhood cancers. Along with a team of international researchers and IBM, Ching Lau, MD, is actively searching for the right drug compound that could affect the key molecules and proteins that control cancer cells in several common childhood cancers. Finding drug candidates can be an expensive and slow process.
Connecticut Children’s Medical Center, The Jackson Laboratory (JAX) for Genomic Medicine, and the UConn School of Medicine have made their first joint appointment: the distinguished pediatric oncologist and cancer researcher Ching C. Lau, M.D., Ph.D.
Leading pediatric endocrinologist and scientist, Dr. David A. Weinstein and his world-renowned Glycogen Storage Disease (GSD) Program is moving to Connecticut’s UConn School of Medicine and Connecticut Children’s Medical Center in early 2017.